Guillain-Barré syndrome after exposure to influenza virus (Q28291850)

2

0 references

Bernd C Kieseier

3

object named as

Bernd C Kieseier

0 references

author name string

Helmar C. Lehmann

1

1 reference

Europe PubMed Central

PubMed publication ID

20797646

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797646

2 July 2024

Richard A. C. Hughes

4

1 reference

Europe PubMed Central

PubMed publication ID

20797646

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797646

full work available at URL

2 July 2024

language of work or name

English

0 references

publication date

September 2010

0 references

https://api.elsevier.com/content/article/PII:S1473309910701407?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(10)70140-7

https://api.elsevier.com/content/article/PII:S1473309910701407?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(10)70140-7

Lancet Infectious Diseases

2 July 2024

published in

0 references

volume

10

0 references

issue

9

0 references

page(s)

643-51

0 references

cites work

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

1 reference

7 January 2021

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Carbohydrate mimicry: a new paradigm of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Recent developments in Miller Fisher syndrome and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The immunobiology of Guillain-Barré syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Epidemiological study of Guillain-Barré syndrome in south east England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Epidemiology of the Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Why delaying levodopa is a good treatment strategy in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Incidence of Guillain-Barré syndrome in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Motor nerve biopsy in severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Nerve biopsy in children with severe Guillain-Barré syndrome and inexcitable motor nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Structural requirements of anti-GD1a antibodies determine their target specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Acute conduction block in vitro following exposure to antiganglioside sera.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Binding kinetics of influenza viruses to sialic acid-containing carbohydrates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Neuraminidase inhibitors for influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The persistent legacy of the 1918 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Post-influenzal peripheral neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome and virus of influenza A (Asian strain); report of two fatal cases during the 1957 epidemic in Wales.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome and influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome, greater Paris area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Respiratory syncytial virus infection in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome related to pandemic influenza A (H1N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Reflections on the 1976 swine flu vaccination program.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome following influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré Syndrome After Influenza Vaccination in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Immunological parameters in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Recurrences, vaccinations and long-term symptoms in GBS and CIDP.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Recurrent Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Recurrent Guillain-Barré syndrome following influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Influenza vaccine and the risk of relapse of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

[Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Guillain-Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

A reversible paralytic syndrome with anti-GD1b antibodies following influenza immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

The influenza vaccine licensing process.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970140-7

7 January 2021

Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S1473-3099(10)70140-7

The geography and mortality of the 1918 influenza pandemic

64

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(10)70140-7

The Nervous Conditions Associated with Influenza

2 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(10)70140-7